Literature DB >> 10872467

CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals.

A J Shaywitz1, M E Greenberg.   

Abstract

Extracellular stimuli elicit changes in gene expression in target cells by activating intracellular protein kinase cascades that phosphorylate transcription factors within the nucleus. One of the best characterized stimulus-induced transcription factors, cyclic AMP response element (CRE)-binding protein (CREB), activates transcription of target genes in response to a diverse array of stimuli, including peptide hormones, growth factors, and neuronal activity, that activate a variety of protein kinases including protein kinase A (PKA), pp90 ribosomal S6 kinase (pp90RSK), and Ca2+/calmodulin-dependent protein kinases (CaMKs)[corrected]. These kinases all phosphorylate CREB at a particular residue, serine 133 (Ser133), and phosphorylation of Ser133 is required for CREB-mediated transcription. Despite this common feature, the mechanism by which CREB activates transcription varies depending on the stimulus. In some cases, signaling pathways target additional sites on CREB or proteins associated with CREB, permitting CREB to regulate distinct programs of gene expression under different conditions of stimulation. This review discusses the molecular mechanisms by which Ser133-phosphorylated CREB activates transcription, intracellular signaling pathways that lead to phosphorylation of CREB at Ser133, and features of each signaling pathway that impart specificity at the level of CREB activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10872467     DOI: 10.1146/annurev.biochem.68.1.821

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  664 in total

Review 1.  The many dimensions of cAMP signaling.

Authors:  J H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  Protein kinase A-independent responses to beta-adrenoceptor agonists.

Authors:  G Dent
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

3.  A dominant negative Egr inhibitor blocks nerve growth factor-induced neurite outgrowth by suppressing c-Jun activation: role of an Egr/c-Jun complex.

Authors:  Yechiel Levkovitz; Jay M Baraban
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

4.  Circadian regulation of nocturnin transcription by phosphorylated CREB in Xenopus retinal photoreceptor cells.

Authors:  Xiaorong Liu; Carla B Green
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

Review 5.  Chemokine receptors and neural function.

Authors:  Charlene Cho; Richard J Miller
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

6.  RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2.

Authors:  Yuan Xiao Zhu; Hongwei Yin; Laura A Bruins; Chang-Xin Shi; Patrick Jedlowski; Meraj Aziz; Chris Sereduk; Klaus Martin Kortuem; Jessica E Schmidt; Mia Champion; Esteban Braggio; A Keith Stewart
Journal:  Blood       Date:  2014-11-13       Impact factor: 22.113

7.  Mechanistic insights into the activation of ester prodrugs of 666-15.

Authors:  Fuchun Xie; Pedro Martín-Acosta; Bingbing X Li; Xiangshu Xiao
Journal:  Bioorg Med Chem Lett       Date:  2020-07-28       Impact factor: 2.823

8.  The cyclic AMP response element-binding protein (CREB) mediates smooth muscle cell proliferation in response to angiotensin II.

Authors:  Peter Molnar; Raissa Perrault; Sherif Louis; Peter Zahradka
Journal:  J Cell Commun Signal       Date:  2013-12-11       Impact factor: 5.782

9.  Hotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities.

Authors:  Timothy A Dinh; Ramja Sritharan; F Donelson Smith; Adam B Francisco; Rosanna K Ma; Rodica P Bunaciu; Matt Kanke; Charles G Danko; Andrew P Massa; John D Scott; Praveen Sethupathy
Journal:  Cell Rep       Date:  2020-04-14       Impact factor: 9.423

10.  A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's disease.

Authors:  Danielle A Simmons; Nadia P Belichenko; Tao Yang; Christina Condon; Marie Monbureau; Mehrdad Shamloo; Deqiang Jing; Stephen M Massa; Frank M Longo
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.